1. Home
  2. WKSP vs HIND Comparison

WKSP vs HIND Comparison

Compare WKSP & HIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Worksport Ltd.

WKSP

Worksport Ltd.

HOLD

Current Price

$0.82

Market Cap

13.2M

ML Signal

HOLD

Logo Vyome Holdings Inc.

HIND

Vyome Holdings Inc.

N/A

Current Price

$2.23

Market Cap

15.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
WKSP
HIND
Founded
2003
2017
Country
United States
United States
Employees
81
18
Industry
Auto Parts:O.E.M.
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
13.2M
15.2M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
WKSP
HIND
Price
$0.82
$2.23
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$9.25
$15.00
AVG Volume (30 Days)
11.1M
15.4K
Earning Date
05-15-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$131.96
N/A
Revenue Next Year
$24.81
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.57
$1.75
52 Week High
$4.40
$12.87

Technical Indicators

Market Signals
Indicator
WKSP
HIND
Relative Strength Index (RSI) 46.69 49.34
Support Level $0.63 $1.99
Resistance Level $1.36 $2.33
Average True Range (ATR) 0.16 0.09
MACD -0.02 0.00
Stochastic Oscillator 11.22 43.70

Price Performance

Historical Comparison
WKSP
HIND

About WKSP Worksport Ltd.

Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers. It operates in two reporting segments for financial reporting purposes: Hard Tonneau Covers and Soft Tonneau Covers. Geographically, the company operates in Canada, United States and Other Countries.

About HIND Vyome Holdings Inc.

Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of Molecular Replacement Therapeutics (MRT) in India: a dandruff lotion and shampoo. It operates in two segments: pharmaceutical products, which generate the maximum revenue, and biotechnology.

Share on Social Networks: